These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19640859)

  • 21. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.
    Kosaka T; Yatabe Y; Onozato R; Kuwano H; Mitsudomi T
    J Thorac Oncol; 2009 Jan; 4(1):22-9. PubMed ID: 19096302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].
    Zhang Z; Wu X; Ying J; Li J; Qiu T; Guo H; Zhao H; Shan L; Ling Y
    Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):199-205. PubMed ID: 25936883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population.
    Fakhruddin N; Mahfouz R; Farhat F; Tfayli A; Abdelkhalik R; Jabbour M; Yehia L; Mahfoud Z; Zaatari G
    Oncol Rep; 2014 Nov; 32(5):2223-9. PubMed ID: 25120214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.
    Santis G; Angell R; Nickless G; Quinn A; Herbert A; Cane P; Spicer J; Breen R; McLean E; Tobal K
    PLoS One; 2011; 6(9):e25191. PubMed ID: 21949883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration.
    Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Kubo R; Mohammed S; Miyagi Y; Matsukuma S; Sekine Y; Fujisawa T
    Chest; 2007 Aug; 132(2):597-602. PubMed ID: 17573511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
    Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
    Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
    Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.
    Giannini R; Lupi C; Sensi E; Alì G; Proietti A; Boldrini L; Servadio A; Giordano M; Macerola E; Bruno R; Borrelli N; Chella A; Melfi F; Lucchi M; Ribechini A; Vasile E; Cappuzzo F; Mussi A; Fontanini G
    Oncol Rep; 2016 Aug; 36(2):1166-72. PubMed ID: 27373829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study.
    Malapelle U; de Rosa N; Rocco D; Bellevicine C; Crispino C; Illiano A; Piantedosi FV; Nappi O; Troncone G
    J Clin Pathol; 2012 Jan; 65(1):87-91. PubMed ID: 21945923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive genotyping of somatic mutations in the EGFR, KRAS, PIK3CA, BRAF genes from NSCLC patients using hydrogel biochips.
    Emelyanova M; Arkhipova K; Mazurenko N; Chudinov A; Demidova I; Zborovskaya I; Lyubchenko L; Zasedatelev A; Nasedkina T
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):255-65. PubMed ID: 25153497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma.
    Betz BL; Roh MH; Weigelin HC; Placido JB; Schmidt LA; Farmen S; Arenberg DA; Kalemkerian GP; Knoepp SM
    Am J Clin Pathol; 2011 Oct; 136(4):564-71. PubMed ID: 21917678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
    Wang S; Wang Z
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):30-9. PubMed ID: 25445553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non-small cell lung cancer.
    Peters MJ; Bowden JJ; Carpenter P; Lewis J; Solomon B
    Intern Med J; 2014 Jun; 44(6):575-80. PubMed ID: 24720523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
    Jia XL; Chen G
    Lung Cancer; 2011 Dec; 74(3):396-400. PubMed ID: 21592614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients.
    Ulivi P; Zoli W; Chiadini E; Capelli L; Candoli P; Calistri D; Silvestrini R; Puccetti M
    Eur Respir J; 2012 Jul; 40(1):267-9. PubMed ID: 22753836
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect.
    Munfus-McCray D; Cui M; Zhang Z; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2013 Jul; 44(7):1286-92. PubMed ID: 23337026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer.
    Lee SE; Lee SY; Park HK; Oh SY; Kim HJ; Lee KY; Kim WS
    J Korean Med Sci; 2016 Aug; 31(8):1224-30. PubMed ID: 27478332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.
    van Eijk R; Licht J; Schrumpf M; Talebian Yazdi M; Ruano D; Forte GI; Nederlof PM; Veselic M; Rabe KF; Annema JT; Smit V; Morreau H; van Wezel T
    PLoS One; 2011 Mar; 6(3):e17791. PubMed ID: 21408138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.
    Stella GM; Scabini R; Inghilleri S; Cemmi F; Corso S; Pozzi E; Morbini P; Valentini A; Dore R; Ferrari S; Luisetti M; Zorzetto M
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1327-35. PubMed ID: 23644698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.